Resources
Access valuable resources and articles on psilocybin facilitation, preparation, and integration. Learn more about safe psychedelic practices from our experts in
Bend, Oregon.
When psychedelics entered American history.
How to Change Your Mind documentary.
Psilocybin, the active compound in certain psychedelic mushrooms, has shown significant promise in treating treatment-resistant depression (TRD). Several scientific studies highlight its potential and the mechanisms by which it may help
Clinical Trials and Efficacy:
- A large multicenter clinical trial conducted by COMPASS Pathways across 22 international sites demonstrated that a single 25 mg dose of psilocybin, combined with psychological support, significantly reduced depressive symptoms in participants with TRD. The study found that those who received the 25 mg dose reported a greater reduction in depression levels compared to those who received a 1 mg control dose (King’s College London).
- Another study published in the New England Journal of Medicine showed that psilocybin can reduce depression scores significantly in people with TRD. Participants reported a notable reduction in depression severity three weeks after a single dose of 25 mg psilocybin (King’s College London).
Neurobiological Effects:
- Psilocybin impacts the brain’s default mode network (DMN), which is often overactive in individuals with depression. By disrupting the DMN, psilocybin can reduce rumination and rigid negative thought patterns, providing a reset for the brain’s neural circuits (ScienceDaily).
- It promotes neuroplasticity, allowing the brain to form new connections. This can help individuals break free from entrenched patterns of thinking and behavior that contribute to depression (ScienceDaily) (King’s College London).
Therapeutic Experience:
- During the therapeutic sessions, the psychedelic effects of psilocybin typically last between six to eight hours, during which participants receive psychological support in a calming environment. This support is crucial for helping participants integrate their experiences and insights gained during the session into their daily lives (King’s College London).
The promising results from these studies suggest that psilocybin, when used in a controlled and supportive environment, can be an effective treatment for individuals with treatment-resistant depression. However, it’s important to note that these treatments should be conducted under professional supervision within a clinical setting to ensure safety and efficacy. Further research is ongoing to better understand the long-term benefits and potential risks associated with psilocybin therapy for depression.
For more detailed information, you can check out the studies and articles from sources like ScienceDaily and King’s College London.
Psilocybin has shown significant potential in treating addiction, as evidenced by various scientific studies. Here’s a summary of the findings:
Smoking Cessation:
- A study conducted by Johns Hopkins University found that psilocybin, administered in conjunction with cognitive-behavioral therapy, significantly helped long-term smokers quit. Participants who had previously failed multiple attempts to quit showed a high rate of abstinence following psilocybin sessions. The effects were sustained, with many participants remaining abstinent even at long-term follow-ups (Home) (Hazelden Ford).
Alcohol Use Disorder:
- Research has demonstrated that psilocybin can reduce heavy drinking days in individuals with alcohol dependence. A study involved two doses of psilocybin administered several weeks apart, combined with motivational enhancement therapy. Results showed a significant reduction in alcohol consumption following the psilocybin sessions (Hazelden Ford).
General Substance Use Disorders:
- Psilocybin’s effectiveness extends to various substance use disorders, including alcohol and nicotine dependence. The mechanism involves inducing profound psychological experiences that can lead to lasting changes in behavior and thought patterns. This is often facilitated by increased neuroplasticity and a reset of brain circuits involved in addiction (American Psychological Association).
Mechanisms of Action:
- Psilocybin affects the brain’s default mode network (DMN), which is associated with self-referential thinking and rigid thought patterns. By disrupting the DMN, psilocybin helps break these patterns, allowing for new perspectives and behaviors. This disruption is coupled with enhanced neuroplasticity, helping the brain form new, healthier connections (Home).
These findings are promising, but it’s essential to conduct psilocybin treatments in controlled, clinical settings under professional supervision to ensure safety and efficacy. The growing body of research supports the potential of psilocybin as a valuable tool in treating addiction, offering new hope for those struggling with substance use disorders.
For more detailed information, you can refer to studies from Johns Hopkins University and other leading research institutions.
Psilocybin has shown promise in treating post-traumatic stress disorder (PTSD). Here are some key points from recent scientific studies:
Clinical Findings
Phase 2 Clinical Trials:
- An international, multicenter phase 2 study investigated the use of COMP360 psilocybin in treating PTSD. The study included 22 patients who received a single 25 mg dose of psilocybin along with psychological support. Results showed significant improvements in PTSD symptoms, with patients reporting reduced scores on the Clinician-Administered PTSD Scale (CAPS-5) at both four and twelve weeks post-treatment. The treatment was well-tolerated, with no serious adverse events reported (Psychiatric Times).
Safety and Efficacy:
- Preliminary data from another phase 2 trial indicated that psilocybin was well-tolerated by patients with PTSD, supporting its potential as a safe treatment option. The study emphasized the importance of safety in developing new treatments, with promising initial results encouraging further research (Psychiatric Times).
Mechanisms of Action
Neurogenesis and Neuroplasticity:
- Psilocybin is believed to stimulate the growth of new neurons and synapses, particularly in the hippocampus, a brain region involved in memory and emotional regulation. This neurogenesis can help alleviate the symptoms of PTSD by promoting the repair and growth of brain cells, aiding in the processing and overcoming of traumatic memories (NYU Langone Health).
Fear Extinction:
- Animal studies have shown that psilocybin can facilitate the extinction of conditioned fear responses. This effect is crucial for PTSD treatment, as it helps patients diminish the intensity of traumatic memories and reduce the associated fear and anxiety (NYU Langone Health).
Therapeutic Approach
- Psychological Support:
- Psilocybin treatment for PTSD typically involves psychological support to help patients integrate their experiences. This support is crucial for maximizing the therapeutic benefits of psilocybin and ensuring patients can process and make sense of their psychedelic experiences in a safe environment (Psychiatric Times).
These findings highlight the potential of psilocybin as a promising treatment for PTSD, particularly for individuals who have not responded to traditional therapies. Ongoing research aims to further establish its efficacy and safety, potentially offering new hope for those affected by this challenging condition.
For more detailed information, you can refer to the Psychiatric Times and NYU Langone Health.